" /> Bevacizumab/Cisplatin/Paclitaxel Regimen - CISMeF





Preferred Label : Bevacizumab/Cisplatin/Paclitaxel Regimen;

NCIt synonyms : Platinol/Taxol/Avastin Regimen; Platinol-Taxol-Avastin Regimen; Cisplatin/Paclitaxel/Bevacizumab; Cisplatin-Paclitaxel-Bevacizumab; Cisplatin-Paclitaxel-Bevacizumab Regimen; Cisplatin/Paclitaxel/Bevacizumab Regimen;

NCIt related terms : Cisplatin, Paclitaxel, Bevacizumab; Cisplatin, Paclitaxel, Bevacizumab-adcd; Cisplatin, Paclitaxel, Bevacizumab-bvzr; Cisplatin, Paclitaxel, Bevacizumab-equi; Cisplatin, Paclitaxel, Bevacizumab-awwb; Cisplatin, Paclitaxel, Bevacizumab-aybi; Cisplatin, Paclitaxel, Bevacizumab-maly; Cisplatin, Paclitaxel, Bevacizumab-onbe;

NCIt definition : A regimen consisting of bevacizumab, cisplatin and paclitaxel that is used for the treatment of vulvar and cervical cancer.;

NCI Metathesaurus CUI : CL523552;

Codes from synonyms : 11505; 127389; 127241; 127463; 127167; 127611; 127315; 127537;

Details


You can consult :


Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.